What genetic mutations are commonly found in Multiple Myeloma

Genetic Mutations in Multiple Myeloma

Multiple myeloma involves several important genetic mutations that help doctors understand your disease and plan treatment. Let me explain the most common ones and why they matter.

How Mutations Develop in Myeloma

According to the NCCN Guidelines for Patients: Multiple Myeloma, myeloma starts when genetic changes occur in plasma cells (a type of white blood cell). These mutations cause normal plasma cells to transform into cancerous myeloma cells that multiply uncontrollably and produce abnormal proteins called M proteins.

Key Chromosomal Abnormalities

Your doctors will look for specific changes in your chromosomes—the structures inside cells that contain your genetic instructions. Here are the most important ones:

High-Risk and Very High-Risk Changes

The NCCN Guidelines identify several chromosomal changes that indicate more aggressive myeloma:

High-Risk Changes (any one of these):

• Deletion of chromosome 17p – Loss of part or all of this chromosome
• Translocation between chromosomes 4 and 14 – Parts of these chromosomes swap places
• Translocation between chromosomes 14 and 16 – Another chromosomal swap
• Translocation between chromosomes 14 and 20 – Yet another swap pattern
• Amplification of chromosome 1q21 – Extra copies of part of chromosome 1, linked with more aggressive disease
• Translocation within the MYC gene – A specific gene involved in cell growth
• TP53 gene mutation – Damage to this important tumor-suppressor gene

Very High-Risk: Having 2 or more of these abnormalities together indicates very high-risk disease.

Other Important Chromosomal Changes

• Deletion of chromosome 13 – May indicate more aggressive myeloma
• Duplication/amplification of chromosome 1q21 – Associated with more aggressive disease progression

Why These Mutations Matter

According to NCCN Guidelines, identifying these genetic changes helps your care team:

1. Predict how quickly your myeloma might progress – High-risk mutations suggest the cancer may come back faster or be harder to treat
2. Plan your treatment strategy – Different mutations may respond better to certain therapies
3. Assess your prognosis – Understanding your genetic profile helps set realistic expectations

How Mutations Are Detected

Your doctors will use a test called FISH (Fluorescence In Situ Hybridization) on your bone marrow biopsy sample. This test uses special dyes to look for abnormal changes in your cells' genes and chromosomes. The NCCN Guidelines note that FISH testing is an important part of your initial diagnosis.

Important Context

It's crucial to understand that:

• Not everyone has all these mutations – Your specific genetic profile is unique to you
• Having a mutation doesn't determine your outcome alone – Many other factors affect how you'll respond to treatment
• New treatments are changing outcomes – Even patients with high-risk mutations now have more effective treatment options than ever before

Questions to Ask Your Care Team

To better understand YOUR specific genetic profile:

1. What chromosomal abnormalities were found in my bone marrow biopsy?
2. Do I have high-risk, very high-risk, or standard-risk myeloma based on my genetic testing?
3. How do my specific mutations affect my treatment recommendations?
4. Will my genetic results change if my myeloma comes back or progresses?
5. Are there clinical trials available for patients with my specific genetic profile?

---

Sources:

• NCCN Guidelines for Patients: Multiple Myeloma, 2025 (Testing for myeloma section on bone tissue tests and chromosomal abnormalities)
• NCCN Guidelines for Patients: Multiple Myeloma, 2025 (Discussion of high-risk and very high-risk disease classification)

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.